:

As part of the IMMUNEBRIDGE project, data and biosamples from nine population- and hospital-based studies were analysed to provide estimates of protection against SARS-CoV-2 infections and severe COVID-19 infections between June and November 2022. The researchers found relevant protection gaps in the oldest age group and in people with comorbidities.